The stock market has been experiencing some fluctuations in the midcap segment today. According to the latest market summary, the Midcap (BSE midcap) index is down by -0.15%, and in the last 5 days, it has seen a decline of -3.48%. This segment has been the best performer, with IRFC showing a return of 10.38%. However, Glaxosmithkline Pharma has been the worst performer with a return of -5.95%. Among the midcap stocks, Sona BLW Precision Industries is showing a mildly bearish to mildly bullish trend, while Astral and Aditya Birla Fashion are expected to remain sideways to mildly bullish. On the other hand, Endurance Technologies and Gillette India are showing a bullish to mildly bullish trend. Recently, there has been a change in the technical call for some stocks in this midcap index. The advance-decline ratio for these stocks is 60 advancing and 64 declining, with a ratio of 0.94x. This indicates a mixed trend in the market. Investors should keep an eye on the following stocks as they will be declaring their results in the next few days: Rajesh Exports, Muthoot Finance, Aditya Birla Fashion, Ipca Laboratories, and NMDC on 14th February 2024. In terms of stock score, some stocks in this midcap segment have been upgraded recently. These include Ajanta Pharma, which has been upgraded from Hold to Buy, and IDFC First Bank, which has also been upgraded from Hold to Buy. Investors should consider these changes while making their investment decisions.